Vaccines containing a saponin and a sterol
AssigneeSmithKline Beecham Biologicals s.a.
InventorsNathalie Marie-Josephe Claude Garcon, Martin Friede
Life of this patent
Estimating the term…
Loading patent…
AssigneeSmithKline Beecham Biologicals s.a.
InventorsNathalie Marie-Josephe Claude Garcon, Martin Friede
Estimating the term…
A novel adjuvant composition comprising a sterol (e.g., cholesterol, β-sitosterol, stigmasterol, ergosterol, and ergocalciferol) and saponin fraction (e.g., QS21, also known as QA21) in the form of an immunostimulating complex, or ISCOM, is disclosed. QS21 is an immunologically active saponin fraction having adjuvant activity derived from the bark of Quillaja Saponaria Molina. Previous attempts in the prior art to prepare ISCOMs comprising QS21 were unsuccessful. Thus, the instant application discloses the first successful attempt to prepare ISCOMs comprising purified QS21. Small unilamelar liposomes containing cholesterol, in the absence of any detergent, were prepared, followed by the addition of an aqueous solution of QS21. The claimed compositions will prove useful in the preparation of highly immunogenic vaccine compositions.
An adjuvant composition comprising a sterol and a substantially pure preparation of QS21, characterized in that the adjuvant composition is in the form of an ISCOM.
Dependencies are inferred from the claim text.